TVARDI THERAPEUTICS, INC. (TVRD) Operating income 2016–2025
TVARDI THERAPEUTICS, INC. (TVRD) annual operating income history from SEC filings — each fiscal year as reported.
-$26.7MFY2025 · since FY2016: -$58.4M → -$26.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.7M | +4.8% |
| FY2024 | -$28.1M | +76.9% |
| FY2023 | -$121.5M | -38.8% |
| FY2022 | -$87.5M | +1.7% |
| FY2021 | -$89.1M | -1754.3% |
| FY2020 | $5.4M | +104.8% |
| FY2019 | -$111.7M | -44.3% |
| FY2018 | -$77.4M | -30.1% |
| FY2017 | -$59.5M | -1.9% |
| FY2016 | -$58.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TVRD financial trends
TVRD RevenueTVRD Net incomeTVRD Net marginTVRD Gross profitTVRD Gross marginTVRD Operating marginTVRD Operating cash flowTVRD Free cash flowTVRD Capital expendituresTVRD Return on equityTVRD Stock buybacksTVRD Dividends paidTVRD Total assetsTVRD Total liabilitiesTVRD Shareholders’ equityTVRD overview →